Literature DB >> 32537150

Basic Opioid Pharmacology - An Update.

Arul James1, John Williams2,3.   

Abstract

Opioids are a group of analgesic agents commonly used in clinical practice. The three classical opioid receptors are MOP, DOP and KOP. The NOP (N/OFQ) receptor is considered to be a non-opioid branch of the opioid receptor family. Opioid receptors are G-protein-coupled receptors which cause cellular hyperpolarisation when bound to opioid agonists. Opioids may be classified according to their mode of synthesis into alkaloids, semi-synthetic and synthetic compounds. Opioid use disorder (OUD) is an emerging issue and important lessons can be learnt from the United States where opioid epidemic was declared as a national emergency in 2017. © The British Pain Society 2020.

Entities:  

Keywords:  Opioid pharmacology; analgesics; opioid classification; opioid receptors; opioid use disorder; pharmacokinetics

Year:  2020        PMID: 32537150      PMCID: PMC7265597          DOI: 10.1177/2049463720911986

Source DB:  PubMed          Journal:  Br J Pain        ISSN: 2049-4637


  18 in total

1.  A cellular mechanism for the bidirectional pain-modulating actions of orphanin FQ/nociceptin.

Authors:  Z Pan; N Hirakawa; H L Fields
Journal:  Neuron       Date:  2000-05       Impact factor: 17.173

Review 2.  Opioids for neuropathic pain.

Authors:  E Eisenberg; E McNicol; D B Carr
Journal:  Cochrane Database Syst Rev       Date:  2006-07-19

3.  75 years of opioid research: the exciting but vain quest for the Holy Grail.

Authors:  Alistair D Corbett; Graeme Henderson; Alexander T McKnight; Stewart J Paterson
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

Review 4.  Opioids for chronic low-back pain.

Authors:  A Deshpande; A Furlan; A Mailis-Gagnon; S Atlas; D Turk
Journal:  Cochrane Database Syst Rev       Date:  2007-07-18

Review 5.  Challenges for opioid receptor nomenclature: IUPHAR Review 9.

Authors:  Brian M Cox; Macdonald J Christie; Lakshmi Devi; Lawrence Toll; John R Traynor
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

Review 6.  Pharmacology of nociceptin and its receptor: a novel therapeutic target.

Authors:  G Calo'; R Guerrini; A Rizzi; S Salvadori; D Regoli
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

Review 7.  The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop.

Authors:  Roger Chou; Judith A Turner; Emily B Devine; Ryan N Hansen; Sean D Sullivan; Ian Blazina; Tracy Dana; Christina Bougatsos; Richard A Deyo
Journal:  Ann Intern Med       Date:  2015-02-17       Impact factor: 25.391

8.  Morphine, the Proteus of organic molecules.

Authors:  Paul R Blakemore; James D White
Journal:  Chem Commun (Camb)       Date:  2002-06-07       Impact factor: 6.222

9.  Oxycodone and morphine have distinctly different pharmacological profiles: radioligand binding and behavioural studies in two rat models of neuropathic pain.

Authors:  Carsten K Nielsen; Fraser B Ross; Shahrdad Lotfipour; Kamal S Saini; Stephen R Edwards; Maree T Smith
Journal:  Pain       Date:  2007-04-30       Impact factor: 6.961

Review 10.  Oral or transdermal opioids for osteoarthritis of the knee or hip.

Authors:  Eveline Nüesch; Anne Ws Rutjes; Elaine Husni; Vivian Welch; Peter Jüni
Journal:  Cochrane Database Syst Rev       Date:  2009-10-07
View more
  10 in total

1.  A Survey of Knowledge and Barriers of Healthcare Professionals toward Opioid Analgesics in Cancer Pain Management.

Authors:  Nehad M Ayoub; Malak Jibreel; Khawla Nuseir; Ghaith M Al-Taani
Journal:  Int J Clin Pract       Date:  2022-04-12       Impact factor: 3.149

Review 2.  Aerobic exercise as a promising nonpharmacological therapy for the treatment of substance use disorders.

Authors:  Gigliola Marrero-Cristobal; Ursula Gelpi-Dominguez; Roberto Morales-Silva; John Alvarado-Torres; Joshua Perez-Torres; Yobet Perez-Perez; Marian Sepulveda-Orengo
Journal:  J Neurosci Res       Date:  2021-12-01       Impact factor: 4.433

3.  A Large-Scale Observational Study on the Temporal Trends and Risk Factors of Opioid Overdose: Real-World Evidence for Better Opioids.

Authors:  Jianyuan Deng; Wei Hou; Xinyu Dong; Janos Hajagos; Mary Saltz; Joel Saltz; Fusheng Wang
Journal:  Drugs Real World Outcomes       Date:  2021-05-26

Review 4.  The Convergent Neuroscience of Affective Pain and Substance Use Disorder.

Authors:  Amanda R Pahng; Scott Edwards
Journal:  Alcohol Res       Date:  2021-12-16

Review 5.  Opioids Regulate the Immune System: Focusing on Macrophages and Their Organelles.

Authors:  Shaohua Wen; Yuan Jiang; Shuang Liang; Zhigang Cheng; Xiaoyan Zhu; Qulian Guo
Journal:  Front Pharmacol       Date:  2022-01-12       Impact factor: 5.810

6.  Modulation of the kappa and mu opioid axis for the treatment of chronic pruritus: A review of basic science and clinical implications.

Authors:  Sarina Elmariah; Sarah Chisolm; Thomas Sciascia; Shawn G Kwatra
Journal:  JAAD Int       Date:  2022-04-20

7.  A Critical Review on the Pharmacodynamics and Pharmacokinetics of Non-steroidal Anti-inflammatory Drugs and Opioid Drugs Used in Reptiles.

Authors:  Allison Kah Yann Ting; Vanessa Shu Yu Tay; Hui Ting Chng; Shangzhe Xie
Journal:  Vet Anim Sci       Date:  2022-08-08

8.  Effectiveness and Safety of Codeine and Levodropropizine in Patients With Chronic Cough.

Authors:  Sang Pyo Lee; Sang Min Lee; Byung-Jae Lee; Sung-Yoon Kang
Journal:  J Korean Med Sci       Date:  2022-09-19       Impact factor: 5.354

Review 9.  Modulatory Potential of Cannabidiol on the Opioid-Induced Inflammatory Response.

Authors:  Clare T Johnson; Heather B Bradshaw
Journal:  Cannabis Cannabinoid Res       Date:  2021-06

10.  Respiratory depression and analgesia by opioid drugs in freely behaving larval zebrafish.

Authors:  Shenhab Zaig; Carolina da Silveira Scarpellini; Gaspard Montandon
Journal:  Elife       Date:  2021-03-15       Impact factor: 8.140

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.